#Pharmaceuticals

We are continuing with our mini-series on Healthcare stocks by venturing into the biotech space. BioVaxys insiders are betting big on their firm's novel approach to tackling cancer and COVID-19.

Will lower bond yields help send Bright Minds Biosciences (DRUG) on a trip higher? The CEO seems to be betting the stock may have hit its lows.

INK returns to the pharmaceuticals industry today to look at a newly trading stock that has debuted in our rankings in the top 30%